116 related articles for article (PubMed ID: 2783878)
1. Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing.
Schilsky RL; Choi KE; Vokes EE; Guaspari A; Guarnieri C; Whaling S; Liebner MA
Cancer; 1989 Mar; 63(6 Suppl):1018-21. PubMed ID: 2783878
[TBL] [Abstract][Full Text] [Related]
2. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
Vokes EE; Schilsky RL; Weichselbaum RR; Kozloff MF; Panje WR
J Clin Oncol; 1990 Feb; 8(2):241-7. PubMed ID: 1688926
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Wright JE; Norris CM; Busse PM; Lucarini JW; Fallon BG; Casey D; Andersen JW; Klein R
Ann Intern Med; 1990 Feb; 112(3):167-72. PubMed ID: 2297193
[TBL] [Abstract][Full Text] [Related]
4. Toxicity and antitumor activity of 5-fluorouracil in combination with leucovorin. Role of dose schedule and route of administration of leucovorin.
Rustum YM
Cancer; 1989 Mar; 63(6 Suppl):1013-7. PubMed ID: 2783877
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
Vokes EE; Choi KE; Schilsky RL; Moran WJ; Guarnieri CM; Weichselbaum RR; Panje WR
J Clin Oncol; 1988 Apr; 6(4):618-26. PubMed ID: 3258629
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration.
Schilsky RL; Ratain MJ
J Natl Cancer Inst; 1990 Sep; 82(17):1411-5. PubMed ID: 2388292
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
Vokes EE; Mick R; Kies MS; Dolan ME; Malone D; Athanasiadis I; Haraf DJ; Kozloff M; Weichselbaum RR; Ratain MJ
J Clin Oncol; 1996 May; 14(5):1663-71. PubMed ID: 8622086
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Schneider M; Etienne MC; Milano G; Thyss A; Otto J; Dassonville O; Mobayen H; Saudes L; Guillot T; Demard F
J Clin Oncol; 1995 Jul; 13(7):1656-62. PubMed ID: 7602355
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of leucovorin (D,L-5-formyltetrahydrofolate) after intravenous injection and constant intravenous infusion.
Straw JA; Newman EM; Doroshow JH
NCI Monogr; 1987; (5):41-5. PubMed ID: 3501545
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
Vokes EE; Ratain MJ; Mick R; McEvilly JM; Haraf D; Kozloff M; Hamasaki V; Weichselbaum RR; Panje WR; Wenig B
J Clin Oncol; 1993 Feb; 11(2):360-8. PubMed ID: 8426214
[TBL] [Abstract][Full Text] [Related]
12. Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma.
Trave F; Rustum YM; Petrelli NJ; Herrera L; Mittelman A; Frank C; Creaven PJ
J Clin Oncol; 1988 Jul; 6(7):1184-91. PubMed ID: 3260621
[TBL] [Abstract][Full Text] [Related]
13. Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
Pazdur R
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):35-9. PubMed ID: 9348565
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis of (6S)-5-formyltetrahydrofolate (1-CF), (6R)-5-formyltetrahydrofolate (d-CF) and 5-methyltetrahydrofolate (5-CH3-THF) in patients receiving constant i.v. infusion of high-dose (6R,S)-5-formyltetrahydrofolate (leucovorin).
Straw JA; Newman EM
Adv Exp Med Biol; 1988; 244():53-8. PubMed ID: 3266829
[No Abstract] [Full Text] [Related]
15. Clinical pharmacokinetics of fluorouracil and folinic acid.
Schalhorn A; Kühl M
Semin Oncol; 1992 Apr; 19(2 Suppl 3):82-92. PubMed ID: 1557660
[TBL] [Abstract][Full Text] [Related]
16. Fluorouracil combined with the pure (6S)-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma: a phase I-II study.
Machover D; Grison X; Goldschmidt E; Zittoun J; Lotz JP; Metzger G; Richaud J; Hannoun L; Marquet J; Guillot T
J Natl Cancer Inst; 1992 Mar; 84(5):321-7. PubMed ID: 1738182
[TBL] [Abstract][Full Text] [Related]
17. Phase I, pharmacokinetic, and bone marrow drug-level studies of tri-monthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers.
Ho YF; Lu WC; Chen RR; Cheng AL; Yeh KH
Anticancer Drugs; 2011 Mar; 22(3):290-8. PubMed ID: 21150775
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with leucovorin and 5-fluorouracil.
Laufman LR; Brenckman WD; Stydnicki KA; Morgan ED; Collier M; Knick VB; Duch DS; Mullin R; Ferone R
Cancer; 1989 Mar; 63(6 Suppl):1031-5. PubMed ID: 2783880
[TBL] [Abstract][Full Text] [Related]
19. [Phase I study of 5-fluorouracil and l-leucovorin].
Sasaki T; Ota K; Wakui A; Akazawa S; Ogawa M; Ariyoshi Y; Yura J; Inagaki J; Hoshino A; Abe T
Gan To Kagaku Ryoho; 1993 Mar; 20(4):485-91. PubMed ID: 8452386
[TBL] [Abstract][Full Text] [Related]
20. Resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate by chiral high-performance liquid chromatography.
Choi KE; Schilsky RL
Anal Biochem; 1988 Feb; 168(2):398-404. PubMed ID: 2834981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
